Oxford Biomedica Investor Relations Material
Latest events
H2 2024
Oxford Biomedica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oxford Biomedica plc
Access all reports
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development and bioprocessing of cell and gene therapy products in Europe and internationally. The company's products are designed to treat diseases by replacing or enhancing a patient's defective genes with normal or healthy copies in order to restore or correct its function. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.
Key slides for Oxford Biomedica plc
H2 2024
Oxford Biomedica plc
H2 2024
Oxford Biomedica plc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
OXB
Country
🇬🇧 United Kingdom